These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6634352)

  • 21. NTP Toxicology and Carcinogenesis Studies of Nitromethane (CAS No. 75-52-5) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Feb; 461():1-289. PubMed ID: 12587015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicology and carcinogenesis studies of propargyl alcohol (CAS No. 107-19-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Sep; (552):1-172. PubMed ID: 18974778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.
    Astell KJ; Mathai ML; McAinch AJ; Stathis CG; Su XQ
    Complement Ther Med; 2013 Jun; 21(3):180-9. PubMed ID: 23642949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical aversion conditioning in the treatment of alcoholism: further comments.
    Wilson GT
    Behav Res Ther; 1991; 29(5):415-9; discussion 421-8. PubMed ID: 1741731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrical aversion therapy with alcoholics: a comparative follow-up study.
    Glover JH; McCue PA
    Br J Psychiatry; 1977 Mar; 130():279-86. PubMed ID: 843777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral weight reduction program for mentally retarded adult females.
    Fisher E
    Percept Mot Skills; 1986 Apr; 62(2):359-62. PubMed ID: 3503237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise, and combination interventions.
    Skender ML; Goodrick GK; Del Junco DJ; Reeves RS; Darnell L; Gotto AM; Foreyt JP
    J Am Diet Assoc; 1996 Apr; 96(4):342-6. PubMed ID: 8598434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Mar; (578):1-183. PubMed ID: 23652021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Adventure therapy' combined with cognitive-behavioral treatment for overweight adolescents.
    Jelalian E; Mehlenbeck R; Lloyd-Richardson EE; Birmaher V; Wing RR
    Int J Obes (Lond); 2006 Jan; 30(1):31-9. PubMed ID: 16158087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment predictors of attrition and successful weight management in women.
    Teixeira PJ; Going SB; Houtkooper LB; Cussler EC; Metcalfe LL; Blew RM; Sardinha LB; Lohman TG
    Int J Obes Relat Metab Disord; 2004 Sep; 28(9):1124-33. PubMed ID: 15263921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicology and carcinogenesis studies of diethylamine (CAS No. 109-89-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2011 Oct; (566):1-174. PubMed ID: 22127322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aversion conditioning treatment of alcoholism.
    Holzinger R; Mortimer R; Van Dusen W
    Am J Psychiatry; 1967 Aug; 124(2):246-7. PubMed ID: 4951586
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of aversion in the rapid-smoking treatment procedure.
    Norton GR; Barske B
    Addict Behav; 1977; 2(1):21-5. PubMed ID: 848373
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic nailbiting: a controlled comparison of competing response and mild aversion treatments.
    Allen KW
    Behav Res Ther; 1996 Mar; 34(3):269-72. PubMed ID: 8881096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of cigarette smoking through self-administered aversion conditioning: a new treatment model with implications for public health.
    Berecz JM
    Soc Sci Med (1967); 1972 Feb; 6(1):57-66. PubMed ID: 5016439
    [No Abstract]   [Full Text] [Related]  

  • 38. Treating nailbiting: a comparative analysis of mild aversion and competing response therapies.
    Silber KP; Haynes CE
    Behav Res Ther; 1992 Jan; 30(1):15-22. PubMed ID: 1540108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emetic and electric shock alcohol aversion therapy: six- and twelve-month follow-up.
    Cannon DS; Baker TB; Wehl CK
    J Consult Clin Psychol; 1981 Jun; 49(3):360-8. PubMed ID: 7276325
    [No Abstract]   [Full Text] [Related]  

  • 40. Reducing junk food palatability and consumption by aversive conditioning.
    Abramson EE; Jones D
    Addict Behav; 1981; 6(2):145-8. PubMed ID: 7270300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.